Trogarzo

Trogarzo is a prescription medication used to treat HIV type 1 (HIV-1) infection in adults with multidrug resistant HIV, or HIV that is no longer treated by other currently available anti-HIV medications. Trogarzo should be used in combination with other anti-HIV medications. 

Trogarzo belongs to a group of drugs called biologics. It is an antibody created specifically to protect T-cells from the virus. Trogarzo binds to the T-cell’s surface to block HIV-1 from entering. This can help protect the T-cell and reduce the viral load.

This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional once every 2 weeks.

Common side effects of Trogarzo include diarrhea, nausea and rash. 

Trogarzo can also cause dizziness. Do not drive or operate heavy machinery until you know how Trogarzo affects you.

Trogarzo is a prescription medication used to treat HIV type 1 (HIV-1) infection in adults with multidrug resistant HIV, or HIV that is no longer treated by other currently available anti-HIV medications. Trogarzo should be used in combination with other anti-HIV medications. 

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Serious side effects have been reported with Trogarzo. See the “Trogarzo Precautions” section.

Common side effects of Trogarzo include the following:

• diarrhea
• dizziness
• nausea
• rash

This is not a complete list of Trogarzo side effects. Ask your doctor or pharmacist for more information.

Tell your doctor if you have any side effects that bother you or that do not go away.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

No drug interactions have been studied by the manufacturer. However, you should tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Not all drug interactions are known or reported and new drug interactions are continually being reported.

Serious side effects have been reported with Trogarzo including changes in your immune system (also called immune reconstitution inflammatory syndrome). Tell your healthcare provider right away if you start having new symptoms after starting treatment with Trogarzo. 

Trogarzo can cause drowsiness. Do not drive or operate heavy machinery until you know how Trogarzo affects you.

Do not take Trogarzo if you are allergic to Trogarzo or to any of its ingredients.

Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Trogarzo, there are no specific foods that you must exclude from your diet when receiving this medication.

Before taking Trogarzo, tell your doctor about all of your medical conditions. Especially tell your doctor if you:

• are allergic to Trogarzo or to any of its ingredients.
• are pregnant or plan to become pregnant. There is a pregnancy registry for women who take anti-HIV medications during pregnancy. Talk with your healthcare provider about how to take part in this registry. 
• are breastfeeding or plan to breastfeed. You should not breastfeed if you have HIV-1 because of the risk of passing the infection to your baby. Talk with your healthcare provider to decide the best way to feed your baby. 

Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.

Tell your doctor if you are pregnant or plan to become pregnant.

The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.

Trogarzo falls into category C. No studies have been done in animals, and no well-controlled studies have been done in pregnant women. Trogarzo should be given to a pregnant woman only if clearly needed.

There is a pregnancy registry for women who take anti-HIV medications during pregnancy. Talk with your healthcare provider about how to take part in this registry. 

Tell your doctor if you are breastfeeding or plan to breastfeed. You should not breastfeed if you have HIV-1 because of the risk of passing the infection to your baby. Talk with your healthcare provider to decide the best way to feed your baby. 

Take Trogarzo exactly as prescribed.

This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional. You will receive Trogarzo over 15 to 30 minutes. Your healthcare provider will monitor you during Trogarzo infusion and for a period of time after the infusion is complete. 

You will receive Trogarzo every 2 weeks. It is very important to receive Trogarzo every 2 weeks. Do not change the schedule of your Trogarzo infusions or any of your anti-HIV medicines without talking to your healthcare provider first. 

Tell your healthcare provider right away if you stop receiving Trogarzo infusions or stop taking any other anti-HIV medicines. 

Take this medication exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.

The dose your doctor recommends may be based on the following:

• other medical conditions you have
• how you respond to this medication

The recommended dose of Trogarzo for the treatment of multidrug resistant HIV-1 infection in adults is a single loading dose of 2,000 mg once, followed by a maintenance  dose of 800 mg every 2 weeks. All Trogarzo doses will by administered into a vein (IV) over 15 to 30 minutes by a trained healthcare professional. 

If Trogarzo is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur. However, if overdose is suspected, seek emergency medical attention.

• Do not stop taking or change the schedule of your Trogarzo infusions or other anti-HIV medicines without talking to your healthcare provider first. 
• Tell your healthcare provider right away if you stop receiving Trogarzo infusions or stop taking any other anti-HIV medicines. 
• Tell your healthcare provider right away if are pregnant or plan to become pregnant. There is a pregnancy registry for women who take anti-HIV medications during pregnancy. Talk with your healthcare provider about how to take part in this registry. 
• Tell your doctor if you plan to breastfeed. You should not breastfeed if you have HIV-1 because of the risk of passing the infection to your baby. Talk with your healthcare provider to decide the best way to feed your baby.